HM Venture Partners
Venture capitalSan Francisco · Seed–Late Stage · 7 people tracked
Investment thesis
HM Venture Partners focuses on healthcare, investing in biotech and medtech companies globally and across all stages. It aims to help early- and growth-stage healthcare companies accelerate development by leveraging its team's deep domain expertise and an extensive ecosystem of academic institutions, physician networks, and industry experts. This network provides proprietary deal flow, clinical trial site access, and cross-border business development, particularly bridging the US and Chinese markets. The firm emphasizes identifying breakthrough innovations that address significant unmet medical needs and applies cycle-tested, flexible financing strategies to structure favorable transactions and create value. Its most recent fund, HM Healthcare Fund I, primarily targets healthcare breakthroughs in the US.
Source: firm website, verified Aug 7, 2026.
Team · 7 people
from the firm's website & public directories
What they invest in
from 25 of 31 portfolio companiesHealthtech ×18Biotech ×17Medical Devices ×11Deep Tech ×2Digital Health ×1EdTech ×1FemTech ×1Media & Entertainment ×1
HQs:United States×14China×2Germany×1Denmark×1
Investments · 31 tracked
founders shown can be your intro pathBy year:2023 · 12020 · 12017 · 13 dated
Arthrosi Therapeutics is a clinical-stage biotech company developing AR882 (pozdeutinurad), a urate-lowering drug candidate for gout, tophaceous gout, and chronic kidney disease.
BiotechDigital HealthSan Diego, US
BiotechLaguna Hills, US
Litain Yeh(Executive Officer, Director, Promoter)Shunqi Yan(Executive Officer, Director, Promoter)Robert Orr(Executive Officer, Director, Promoter)Yiwei Zong(Director)Jianfeng Fang(Director)
BoardZhang Mingyuan(Director)
Coherent Biopharma (Tongyi Pharmaceutical) is a biopharmaceutical company developing its proprietary Bi-targeting XDC (bi-XDC) conjugate drug platform to make previously undruggable targets treatable, with a focus on oncology.
BiotechDeep TechHealthtech
Baohua Huang(Founder & CEO)
Genfleet Therapeutics (HK: 2595) is a drug development company focused on oncology and immunological diseases, building large- and small-molecule pipelines targeting novel, clinically unvalidated targets and indications.
BiotechHealthtech
DCB technology company for gastrointestinal stenosis.
GIE Medical is a clinical-stage medical device company developing the ProTractX3, a drug-coated balloon for treating benign strictures of the esophagus and bowel.
BiotechHealthtechMedical DevicesPlymouth, US
Lixiao Wang(Founder & Chief Executive Officer)Ian Schorn(Chief Operational Officer)James Ness(Chief Financial Officer)Harrison Malinoff(VP of Operations and Quality)Dave Hendrickson(VP of Research & Development)Drew McClure(VP of Market Development)
HuidaGene Therapeutics is a gene therapy company developing CRISPR-based treatments across R&D pipelines targeting neurology, ophthalmology, and neuromuscular diseases, including MECP2 Duplication Syndrome, Huntington's Disease, ALS, and inherited retinal dystrophies.
BiotechDeep TechHealthtech
Hypertension company acquired by Novo Nordisk.
KBP is a biotechnology research and development organization that discovers and develops new therapies for unmet medical needs.
Biotech
Melodi Health is developing Melodi Matrix, a product aimed at improving breast reconstruction outcomes after mastectomy.
FemTechHealthtechMedical DevicesMinneapolis, US
Matthew Hemsley(Director)Arikha Moses(Director)Robert S White(Director)Sarah Worrell(Executive Officer, Director)Kai Worrell(Director)
HealthtechStewartville, US
David A. Jonas(Executive Officer, Director)Philip Conway(Executive Officer, Director)Sarah L. Grinde(Executive Officer, Director)
BoardAnthony Conway(Director)
Minnesota Medical Technologies develops StaySure, a discreet medical device designed to prevent accidental leakage for people managing fecal incontinence.
HealthtechMedical Devices
Neurotronic is developing Neuviant Multi-organ Denervation (MDN), an investigational catheter-based therapy that delivers ethanol to overactive sympathetic nerves near the kidneys and liver to lower blood sugar and blood pressure.
Novo Nordisk is a pharmaceutical company that develops and markets treatments for diabetes, hemophilia, weight management, and other chronic diseases through innovative drug therapies.
BiotechHealthtechMedical DevicesCopenhagen, DK
OncoC4 is a clinical-stage biopharmaceutical company developing immunotherapy treatments for cancer patients, based on research by its immunologist founders.
BiotechHealthtechRockville, US
Martin Devenport(Executive Officer)Yang Liu(Co-founder)Michael Flaschen(Director)Pan Zheng(Co-founder)
First-in-class biologic drug targeting the CD24-Siglec innate immunity signaling pathway.
BiotechRockville, US
Pan Zheng(Executive Officer)Kun-Liang Guan(Director)Miao Hong(Director)Martin Devenport(Executive Officer)Yang Liu(Executive Officer, Director)Gary Fanger(Director)
BiotechDallas, US
Brian de Beaubien(Executive Officer, Director)David Thompson(Executive Officer, Director)Renee Ryan(Director)Jude Paganelli(Executive Officer, Director)
BoardMartin Sands(Director)Judson Cooper(Director)
Osteal Therapeutics is a musculoskeletal therapeutics company developing medications to treat orthopedic infections and their consequences.
BiotechHealthtechMedical Devices
Sagimet is a clinical-stage biopharmaceutical company developing FASN (fatty acid synthase) inhibitors targeting metabolic and fibrotic disease pathways driven by overproduction of the fatty acid palmitate.
BiotechHealthtech
Urotronic develops drug-coated balloons for interventional urology, including the Optilume products for treating benign prostatic hyperplasia (BPH) and urethral strictures.
HealthtechMedical DevicesPlymouth, US
Junfeng Wang(Director)David Perry(Executive Officer, Director)Tan Ching(Director)Hui Hu(Director, Promoter)Lixiao Wang(Director, Promoter)Doug Kohrs(Director)
Verve Medical is developing the Verve RPD System, an investigational device for renal pelvic denervation—a minimally invasive catheter-based procedure that uses radiofrequency energy to disrupt overactive kidney nerves to lower blood pressure.
HealthtechMedical DevicesSanta Barbara, US
Terry Buelna(Chief Executive Officer/President/CFO)
BoardWayne Wu(Director)
BioNTech develops immunotherapies that use the body's immune system to treat cancer, infectious diseases, and other serious illnesses.
BiotechHealthtech
Zepto develops a targeted liquid biopsy platform for infectious disease diagnostics, offering plasma-based molecular testing through its CLIA reference laboratory and an integrated sample-to-result platform for use in hospital laboratories.
BiotechHealthtechMedical Devices
Exits · 1
IPOs and acquisitions across the tracked portfolioKBPacq. by Novo Nordisk
Frequently asked questions
- What stage does HM Venture Partners invest at?
- HM Venture Partners invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does HM Venture Partners focus on?
- HM Venture Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is HM Venture Partners located?
- HM Venture Partners is headquartered in San Francisco, US.
- Does HM Venture Partners lead rounds?
- Yes, HM Venture Partners leads investment rounds.
Similar investors
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
Khosla Ventures is a venture capital firm known for backing bold, contrarian bets in world-class teams that can reshape entire industries.
Sofinnova is an investment firm that partners with biotech companies from inception through growth, supporting drug development, the regulatory process, company building, and IPO.
OrbiMed is a global healthcare-focused investment firm providing financing and operational support to companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.
Gore Range Capital is a specialized healthcare investment firm building science-led platforms across precision health, regenerative medicine, personalized therapeutics, and longevity. It provides strategic, financial, and clinical guidance to portfolio companies developing next-generation healthcare solutions.